Isolated nail psoriasis may be a sign of psoriatic arthritis

Published Date: 02 Mar 2023

In a review of 87 patients, the authors recorded the clinical and histological characteristics of patients with nail psoriasis.

Read Full News

Latest News

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

FDA Grants Priority Review for Diabetic Foot Ulcer Therapy

The FDA has granted priority review for a novel wound-healing therapy for Wagner Grade 1 diabetic foot ulcers.

Pennsylvania Measles Cases Top 700 After Four Outbreak-related Deaths Reported

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

Fear of Relapse Burdens Patients With Vitiligo

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

Adding IVIG to Prednisone Boosts Outcomes in IIMs

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Smoke Exposure Tied to HS Risk in Children and Teens

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

The FDA has granted priority review for a novel wound-healing therapy for Wagner Grade 1 diabetic foot ulcers.

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

News All Time

Criteria for Prescribing Testosterone: Who Qualifies?

A Brazilian multidisciplinary consensus sets thresholds for the diagnosis and treatment while emphasizing symptom assessment, repeated testing, and attention to the underlying causes.

Prostate Cancer Spending Nearly Quadrupled Over 10 Years

Medicare spending on prostate cancer care rose sharply from 2012 to 2021, driven largely by increased spending on systemic therapies.

Do IL-17 Inhibitors Increase IBD Risk in HS?

A meta-analysis finds no significant increase in the risk for inflammatory bowel disease among patients with hidradenitis suppurativa treated with IL-17 inhibitors.

Adjuvant Anti-PD-1 Boosts OS in Matched Melanoma Cases

Adjuvant anti-PD-1 therapy is tied to higher 5-year overall survival in patients with stage III melanoma in a matched analysis, but the population-level benefit remains unproven, a Danish study finds.

Kennedy Acknowledges One Measles Death in Pennsylvania

U.S. Health Secretary Robert F. Kennedy Jr acknowledged on Friday that measles caused the recent death of an infant in Pennsylvania, citing information from a county...

Do Pilots, Flight Crew Have Higher Cancer Mortality Risk?

Aircrew may be more likely to die from cancers potentially linked to radiation, but can that be attributed to cosmic radiation — and what, if anything, should physicians do differently?

Sunscreen, Collagen: Do Viral Social Media Claims Hold Up?

Viral discussions about sun protection, vitamin D, and oral collagen often outpace the evidence, leaving clinicians to weigh the benefits, limitations, and patient concerns.

AI-Tomography Detects Subclinical Basal Cell Skin Cancers

AI-assisted coherence tomography shows feasibility as a method of detecting basal cell carcinomas when they are still undetectable, but clinical relevance is still being evaluated.

Social Media Tied to Heavier Chemical Product Use in Teens

Teens who follow beauty influencers and watch skincare tutorials use far more personal care products, raising concerns over chemical exposure.

Young Adult Cancer Survival Rates Accelerate

Researchers have analyzed annual survival data between AYA patients aged 15-39 years and patients in younger and older age groups between 1975 and 2017.

GLP1R Expression Tied to Male Pattern Hair Loss

A genetic analysis suggests that increased GLP1R expression is linked to higher risk for male pattern hair loss.

Better Survival Seen With Spartalizumab Addition in Melanoma

More than 500 adults with BRAF V600-mutant cutaneous melanoma were randomly assigned to receive either intravenous spartalizumab plus oral dabrafenib and trametinib or oral dabrafenib and trametinib.

Advances in MCC: Q&A With Paul Nghiem, MD, PhD

Paul Nghiem, MD, PhD, a global expert in Merkel cell carcinoma, spoke with Medscape Dermatology about recent findings and trends in MCC care and research, as well as a look into the future.

Exclusive-Kennedy Asked to Remove Pennsylvania Measles Death From CDC Tally, Sources Say

U.S. Health Secretary Robert F. Kennedy Jr. asked his new CDC director to remove a reference to two Pennsylvania deaths from the agency’s online measles tally after he...

HS Severely Impairs Quality of Life, Even in Mild Disease

Quality of life is severely impaired in patients with hidradenitis suppurativa, including those traditionally classified as having mild disease.

Sofpironium Gel Safety Confirmed in Real-World Use

Real-world surveillance shows adverse events consistent with the known safety profile of sofpironium gel for excessive underarm sweating.

Recommended News For You

Can Accelerated Salvage RT Improve Prostate Cancer Control?

Inconclusive BRCA Results Linked to Higher BC Risk

Breast awareness: What to look for in your self-exam

QOL Maintained With Giredestrant Combo in Advanced BC

Can taking vitamin D supplements every day lower the mortality rate from cancer?

A Century of Schizophrenia: One Disorder or Many?

AI is useful in low-resource areas for triaging breast masses.

Recommended Articles For You

Hematopoietic Aging Load and Disease Susceptibility: Mechanisms, Clinical Implications, and Management 

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches 

Innovative Practices in Hematology in the Digital Era 

Reconstructive Tissue Engineering After Tumor Resection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

2.

Novel ADC Improves Survival in Metastatic TNBC

3.

Novel Agent for Chronic GVHD Wins FDA Approval

4.

Adopted cancer cells and the effects of their presence.

5.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

1.

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer

2.

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review

3.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

4.

Decoding the Future: Cancer Genomics and Radiomics in Oncology

5.

Preventing Developmental Iron Depletion in Childhood

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

2.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

5.

Case-Based Learning: Oncology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot